誉研堂赴港IPO 引领现代中医连锁化

Core Viewpoint - Harbin Yuyantang Traditional Chinese Medicine Clinic Group Co., Ltd. has officially submitted its listing application to the Hong Kong Stock Exchange, with CMB International and Guoyuan International serving as joint sponsors [1] Company Overview - Yuyantang's core service model is based on a "full lifecycle diagnosis and treatment" approach, integrating offline licensed medical institutions with a dedicated online platform to create a comprehensive TCM service system [1] - The model is founded on the TCM philosophy of "preventing disease before it occurs," systematically covering four stages: "pre-disease, desire for disease, already ill, and post-recovery" [1] Market Position - According to a Frost & Sullivan report, Yuyantang ranks second among private chain TCM medical service providers in Northern China based on total revenue from TCM clinics and outpatient services for 2024 [1] - The company ranks first nationwide in terms of revenue from medicinal pastes [1] - Yuyantang has the highest customer repurchase rate among private chain TCM medical service providers in 2024, reflecting strong patient trust [1] Industry Trends - The TCM industry is being driven towards standardization, chain development, and digital transformation by policies such as the "14th Five-Year Plan for TCM Development" [1] - Yuyantang has established a relatively mature compliance operation and standardization system, positioning itself to further consolidate its market position amid increasing industry concentration [1]